BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19766273)

  • 1. Increased left ventricular arrhythmogenicity in metabolic syndrome and relationship with myocardial performance, risk factors for atherosclerosis, and low-grade inflammation.
    Voulgari C; Tentolouris N; Papadogiannis D; Moyssakis I; Perrea D; Kyriaki D; Katsilambros N
    Metabolism; 2010 Feb; 59(2):159-65. PubMed ID: 19766273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of metabolic syndrome on left ventricular myocardial performance.
    Voulgari C; Moyssakis I; Papazafiropoulou A; Perrea D; Kyriaki D; Katsilambros N; Tentolouris N
    Diabetes Metab Res Rev; 2010 Feb; 26(2):121-7. PubMed ID: 20131336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project.
    Ferreira I; Boreham CA; Twisk JW; Gallagher AM; Young IS; Murray LJ; Stehouwer CD
    J Hypertens; 2007 May; 25(5):1009-20. PubMed ID: 17414665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A; Hergenç G; Can G; Küçükdurmaz Z
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.
    Aso Y; Wakabayashi S; Nakano T; Yamamoto R; Takebayashi K; Inukai T
    Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities--cross-sectional study of the general population.
    Azevedo A; Bettencourt P; Almeida PB; Santos AC; Abreu-Lima C; Hense HW; Barros H
    BMC Cardiovasc Disord; 2007 Jun; 7():17. PubMed ID: 17555566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
    J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function.
    Mulè G; Nardi E; Cottone S; Cusimano P; Incalcaterra F; Palermo A; Giandalia M; Geraci C; Buscemi S; Cerasola G
    J Hum Hypertens; 2007 Nov; 21(11):854-60. PubMed ID: 17541385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and C-reactive protein among cardiology patients.
    Chapidze G; Dolidze N; Enquobahrie DA; Kapanadze S; Latsabidze N; Williams MA
    Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
    J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval?
    Salles GF; Cardoso CR; Leocadio SM; Muxfeldt ES
    Am J Hypertens; 2008 Jan; 21(1):47-53. PubMed ID: 18091743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome.
    Guerrero-Romero F; Rodríguez-Morán M
    Diabetes Metab Res Rev; 2006; 22(6):471-6. PubMed ID: 16598698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
    Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
    J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further inflammatory information on metabolic syndrome by adiponectin evaluation.
    Matsushita K; Tamakoshi K; Yatsuya H; Wada K; Otsuka R; Takefuji S; Hotta Y; Kondo T; Murohara T; Toyoshima H
    Int J Cardiol; 2008 Mar; 124(3):339-44. PubMed ID: 17433469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions.
    Min KB; Min JY; Paek D; Cho SI
    Pacing Clin Electrophysiol; 2008 May; 31(5):584-91. PubMed ID: 18439173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the usefulness of inflammation-sensitive biomarkers to reveal potential sex differences in relation to low-grade inflammation in individuals with the metabolic syndrome.
    Rogowski O; Shapira I; Berliner S
    Metabolism; 2008 Sep; 57(9):1221-6. PubMed ID: 18702947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.